Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic Success of Tiotropium/Olodaterol, Measured Using the Clinical COPD Questionnaire (CCQ), in Routine Clinical Practice: A Multinational Non-Interventional Study.
Valipour A, Avdeev S, Barczyk A, Bayer V, Fridlender Z, Georgieva M, Kudela O, Medvedchikov A, Miron R, Sanzharovskaya M, Šileikienė V, Šorli J, Spielmanns M, Szalai Z. Valipour A, et al. Among authors: bayer v. Int J Chron Obstruct Pulmon Dis. 2021 Mar 10;16:615-628. doi: 10.2147/COPD.S291920. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 33731991 Free PMC article. Clinical Trial.
Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients.
Valipour A, Tamm M, Kociánová J, Bayer V, Sanzharovskaya M, Medvedchikov A, Haaksma-Herczegh M, Mucsi J, Fridlender Z, Toma C, Belevskiy A, Matula B, Šorli J. Valipour A, et al. Among authors: bayer v. Int J Chron Obstruct Pulmon Dis. 2019 Oct 11;14:2343-2354. doi: 10.2147/COPD.S204388. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31632003 Free PMC article.
A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid.
Miravitlles M, Verhamme K, Calverley PMA, Dreher M, Bayer V, Gardev A, de la Hoz A, Wedzicha J, Price D. Miravitlles M, et al. Among authors: bayer v. Int J Chron Obstruct Pulmon Dis. 2022 Mar 11;17:545-558. doi: 10.2147/COPD.S350167. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 35309285 Free PMC article.
Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
Wallace AE, Kaila S, Bayer V, Shaikh A, Shinde MU, Willey VJ, Napier MB, Singer JR. Wallace AE, et al. Among authors: bayer v. J Manag Care Spec Pharm. 2019 Feb;25(2):205-217. doi: 10.18553/jmcp.2019.25.2.205. J Manag Care Spec Pharm. 2019. PMID: 30698096 Free PMC article.
Wallace, S. Kaila, V. Zubek, A. Shaikh, M. Shinde, V. Willey, M. Napier, and J. Singer, Healthcare resource utilization, costs, and exacerbation rates in patients with COPD stratified by GOLD airflow limitation classification in a US commercially insured population, …
Wallace, S. Kaila, V. Zubek, A. Shaikh, M. Shinde, V. Willey, M. Napier, and J. Singer, Healthcare resource utilization, costs …
40 results